United States · FDA National Drug Code directory

Lansoprazole

A source-listed medicine record.

Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.

Medicine identity

Source reference
55111-398_c8eb1d41-1fd2-7c06-486c-e6abf08faa6d
Product NDC
55111-398
Form
CAPSULE, DELAYED RELEASE
Composition / generic term
lansoprazole
Labeler
Dr.Reddy's Laboratories Ltd.
Marketing category
ANDA
Marketing start / end (source format)
20101015
Source listing expiry
20261231

Source-listed ingredients

  • LANSOPRAZOLE — 15 mg/1

These values do not establish equivalence or a dose recommendation.

Packages

  • 100 CAPSULE, DELAYED RELEASE in 1 BOTTLE (55111-398-01) · 55111-398-01
  • 500 CAPSULE, DELAYED RELEASE in 1 BOTTLE (55111-398-05) · 55111-398-05
  • 30 CAPSULE, DELAYED RELEASE in 1 BOTTLE (55111-398-30) · 55111-398-30
  • 60 CAPSULE, DELAYED RELEASE in 1 BOTTLE (55111-398-60) · 55111-398-60
  • 1 BLISTER PACK in 1 CARTON (55111-398-79) / 10 CAPSULE, DELAYED RELEASE in 1 BLISTER PACK · 55111-398-79
  • 90 CAPSULE, DELAYED RELEASE in 1 BOTTLE (55111-398-90) · 55111-398-90

Source and coverage

Open FDA National Drug Code directory

Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.

Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.

Browse United States records →